HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 288 filers reported holding HORIZON PHARMA PLC in Q1 2019. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $33,382,000 | +60.7% | 1,263,053 | +18.8% | 2.44% | +24.9% |
| Q4 2018 | $20,774,000 | +6.7% | 1,063,165 | +6.9% | 1.95% | +28.6% |
| Q3 2018 | $19,470,000 | -10.6% | 994,358 | -24.4% | 1.52% | +0.9% |
| Q2 2018 | $21,779,000 | +62.6% | 1,315,149 | +43.3% | 1.50% | +59.1% |
| Q4 2017 | $13,395,000 | +205.9% | 917,471 | +165.6% | 0.95% | +89.6% |
| Q3 2017 | $4,379,000 | -27.0% | 345,386 | -31.7% | 0.50% | -17.5% |
| Q2 2017 | $6,001,000 | -16.1% | 505,590 | +4.5% | 0.60% | -14.4% |
| Q1 2017 | $7,150,000 | -3.8% | 483,763 | +5.3% | 0.71% | +5.4% |
| Q4 2016 | $7,433,000 | -15.4% | 459,386 | -5.2% | 0.67% | -0.1% |
| Q3 2016 | $8,781,000 | +109.9% | 484,356 | +90.7% | 0.67% | +75.0% |
| Q2 2016 | $4,184,000 | +28.1% | 254,046 | +28.9% | 0.38% | +18.2% |
| Q1 2016 | $3,265,000 | +34.9% | 197,047 | +76.4% | 0.32% | +25.5% |
| Q4 2015 | $2,420,000 | +57.2% | 111,682 | +43.8% | 0.26% | +26.3% |
| Q3 2015 | $1,539,000 | – | 77,674 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |